Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011 (2011), Article ID 231595, 6 pages
http://dx.doi.org/10.4061/2011/231595
Research Article

Ceruloplasmin/Transferrin Ratio Changes in Alzheimer's Disease

1Department of Neuroscience, AFaR—Fatebenefratelli Hospital, 00186 Rome, Italy
2Department of Neurology, Campus Bio-Medico University, 00128 Rome, Italy
3Institute of Cognitive Sciences and Technologies (CNR), Fatebenefratelli Hospital, 00186 Rome, Italy
4Department of Radiology, Fatebenefratelli Hospital, 00186 Rome, Italy
5Department of Imaging, San Raffaele Cassino, Via G. Di Biasio 1, 03043 Cassino(FR), Italy

Received 24 September 2010; Accepted 22 November 2010

Academic Editor: Anthony R. White

Copyright © 2011 Rosanna Squitti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Kirkitadze and A. Kowalska, “Molecular mechanisms initiating amyloid β-fibril formation in Alzheimer's disease,” Acta Biochimica Polonica, vol. 52, no. 2, pp. 417–423, 2005. View at Google Scholar · View at Scopus
  2. D. Blacker, J. L. Haines, L. Rodes et al., “ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative,” Neurology, vol. 48, no. 1, pp. 139–147, 1997. View at Google Scholar · View at Scopus
  3. M. Lavados, M. Guillón, M. C. Mujica, L. E. Rojo, P. Fuentes, and R. B. Maccioni, “Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron,” Journal of Alzheimer's Disease, vol. 13, no. 2, pp. 225–232, 2008. View at Google Scholar · View at Scopus
  4. M. A. Smith, X. Zhu, M. Tabaton et al., “Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 19, no. 1, pp. 363–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Bartzokis and T. A. Tishler, “MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease,” Cellular and Molecular Biology, vol. 46, no. 4, pp. 821–833, 2000. View at Google Scholar · View at Scopus
  6. B. Ding, KE. M. Chen, H. W. Ling et al., “Correlation of iron in the hippocampus with MMSE in patients with alzheimer's disease,” Journal of Magnetic Resonance Imaging, vol. 29, no. 4, pp. 793–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Loeffler, J. R. Connor, P. L. Juneau et al., “Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions,” Journal of Neurochemistry, vol. 65, no. 2, pp. 710–724, 1995. View at Google Scholar · View at Scopus
  8. J. F. Schenck, E. A. Zimmerman, Z. Li et al., “High-field magnetic resonance imaging of brain iron in Alzheimer disease,” Topics in Magnetic Resonance Imaging, vol. 17, no. 1, pp. 41–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. R. Cornett, W. R. Markesbery, and W. D. Ehmann, “Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain,” NeuroToxicology, vol. 19, no. 3, pp. 339–346, 1998. View at Google Scholar · View at Scopus
  10. M. A. Deibel, W. D. Ehmann, and W. R. Markesbery, “Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress,” Journal of the Neurological Sciences, vol. 143, no. 1-2, pp. 137–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Dedman, A. Treffry, J. M. Candy et al., “Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients,” Biochemical Journal, vol. 287, no. 2, pp. 509–514, 1992. View at Google Scholar · View at Scopus
  12. J. R. Connor, B. S. Snyder, J. L. Beard, R. E. Fine, and E. J. Mufson, “Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease,” Journal of Neuroscience Research, vol. 31, no. 2, pp. 327–335, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. P. F. Good, D. P. Perl, L. M. Bierer, and J. Schmeidler, “Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study,” Annals of Neurology, vol. 31, no. 3, pp. 286–292, 1992. View at Google Scholar · View at Scopus
  14. K. Jellinger, W. Paulus, I. Grundke-Iqbal, P. Riederer, and M. B. H. Youdim, “Brain iron and ferritin in Parkinson's and Alzheimer's diseases,” Journal of Neural Transmission: Parkinson's Disease and Dementia Section, vol. 2, no. 4, pp. 327–340, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Morris, J. M. Kerwin, and J. A. Edwardson, “Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus,” Neurodegeneration, vol. 3, no. 4, pp. 267–275, 1994. View at Google Scholar · View at Scopus
  16. D. A. Loeffler, P. A. LeWitt, P. L. Juneau et al., “Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders,” Brain Research, vol. 738, no. 2, pp. 265–274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Castellani, M. A. Smith, A. Nunomura, P. L. R. Harris, and G. Perry, “Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?” Free Radical Biology and Medicine, vol. 26, no. 11-12, pp. 1508–1512, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Connor, P. Tucker, M. Johnson, and B. Snyder, “Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease,” Neuroscience Letters, vol. 159, no. 1-2, pp. 88–90, 1993. View at Google Scholar · View at Scopus
  19. J. R. Connor, S. L. Menzies, S. M. ST. Martin, and E. J. Mufson, “A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains,” Journal of Neuroscience Research, vol. 31, no. 1, pp. 75–83, 1992. View at Google Scholar · View at Scopus
  20. G. McKhann, D. Drachman, and M. Folstein, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar · View at Scopus
  21. M. F. Folstein, S. E. Folstein, and P. R. McHugh, ““Mini mental state”. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Squitti, P. Pasqualetti, G. Dal Forno et al., “Excess of serum copper not related to ceruloplasmin in Alzheimer disease,” Neurology, vol. 64, no. 6, pp. 1040–1046, 2005. View at Google Scholar · View at Scopus
  23. R. Squitti, P. M. Rossini, E. Cassetta et al., “D-penicillamine reduces serum oxidative stress in Alzheimer's disease patients,” European Journal of Clinical Investigation, vol. 32, no. 1, pp. 51–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Hixson and D. T. Vernier, “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI,” Journal of Lipid Research, vol. 31, no. 3, pp. 545–548, 1990. View at Google Scholar · View at Scopus
  25. P. Scheltens, D. Leys, F. Barkhof et al., “Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 10, pp. 967–972, 1992. View at Google Scholar · View at Scopus
  26. P. Scheltens, L. J. Launer, F. Barkhof, H. C. Weinstein, and W. A. Van Gool, “Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability,” Journal of Neurology, vol. 242, no. 9, pp. 557–560, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Scheltens, T. Erkinjunti, D. Leys et al., “White matter changes on CT and MRI: an overview of visual rating scales,” European Neurology, vol. 39, no. 2, pp. 80–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Erkinjuntti, D. Inzitari, L. Pantoni et al., “Research criteria for subcortical vascular dementia in clinical trials,” Journal of Neural Transmission, Supplement, no. 59, pp. 23–30, 2000. View at Google Scholar · View at Scopus
  29. E. Bartels, Color-Coded Duplex Ultrasonography of the Cerebral Vessels: Atlas and Manual, Schattauer, Stuttgart, Germany, 1999.
  30. R. Squitti, D. Lupoi, P. Pasqualetti et al., “Elevation of serum copper levels in Alzheimer's disease,” Neurology, vol. 59, no. 8, pp. 1153–1161, 2002. View at Google Scholar · View at Scopus
  31. D. H. O'Leary, J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson Jr., “Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults,” New England Journal of Medicine, vol. 340, no. 1, pp. 14–22, 1999. View at Publisher · View at Google Scholar
  32. R. Aaslid, T. M. Markwalder, and H. Nornes, “Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries,” Journal of Neurosurgery, vol. 57, no. 6, pp. 769–774, 1982. View at Google Scholar · View at Scopus
  33. C. Altamura, R. Squitti, P. Pasqualetti et al., “Ceruloplasmin/Transferrin system is related to clinical status in acute stroke,” Stroke, vol. 40, no. 4, pp. 1282–1288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Duce, A. Tsatsanis, M. A. Cater et al., “Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease,” Cell, vol. 142, no. 6, pp. 857–867, 2010. View at Publisher · View at Google Scholar
  35. A. R. White, R. Reyes, J. F. B. Mercer et al., “Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice,” Brain Research, vol. 842, no. 2, pp. 439–444, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. A. V. Kozlov, V. I. Sergienko, I. A. Vladimirov, and O. A. Azizova, “The antioxidant system of transferrin-ceruloplasmin in experimental hypercholesterolemia,” Byulleten Eksperimentalnoi Biologii i Meditsiny, vol. 98, no. 12, pp. 668–671, 1984. View at Google Scholar · View at Scopus
  37. H. Aksoy, S. Taysi, K. Altinkaynak, E. Bakan, N. Bakan, and Y. Kumtepe, “Antioxidant potential and transferrin, ceruloplasmin, and lipid peroxidation levels in women with preeclampsia,” Journal of Investigative Medicine, vol. 51, no. 5, pp. 284–287, 2003. View at Google Scholar · View at Scopus
  38. Z. Serdar, E. Gür, and O. Develioǧlu, “Serum iron and copper status and oxidative stress in severe and mild preeclampsia,” Cell Biochemistry and Function, vol. 24, no. 3, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. R. E. Fleming, M. C. Migas, C. C. Holden et al., “Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2214–2219, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. J. R. Burdo, D. A. Antonetti, E. B. Wolpert, and J. R. Connor, “Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system,” Neuroscience, vol. 121, no. 4, pp. 883–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Z. Alizadeh, O. T. Njajou, M. R. Millán, A. Hofman, M. M. Breteler, and C. M. van Duijn, “HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam Study,” Neurobiology of Aging, vol. 30, no. 2, pp. 330–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Blázquez, D. De Juan, J. Ruiz-Martínez et al., “Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population,” Neurobiology of Aging, vol. 28, no. 12, pp. 1941–1943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Berlin, G. Chong, H. Chertkow, H. Bergman, N. A. Phillips, and H. M. Schipper, “Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI,” Neurobiology of Aging, vol. 25, no. 4, pp. 465–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. J. H. Robson, D. J. Lehmann, V. L. C. Wimhurst et al., “Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease,” Journal of Medical Genetics, vol. 41, no. 4, pp. 261–265, 2004. View at Google Scholar · View at Scopus
  45. M. Sampietro, L. Caputo, A. Casatta et al., “The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease,” Neurobiology of Aging, vol. 22, no. 4, pp. 563–568, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. D. J. Lehmann, M. Worwood, R. Ellis et al., “Iron genes, iron load and risk of Alzheimer's disease,” Journal of medical genetics, vol. 43, no. 10, article e52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Halliwell, “Free radicals and metal ions in health and disease,” Proceedings of the Nutrition Society, vol. 46, no. 1, pp. 13–26, 1987. View at Google Scholar · View at Scopus
  48. S. J. Van Rensburg, J. Van Zyl, D. Hon et al., “Biochemical model for inflammation of the brain: the effect of iron and transferrin on monocytes and lipid peroxidation,” Metabolic Brain Disease, vol. 19, no. 1-2, pp. 97–112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Scacchi, L. De Bernardini, E. Mantuano, L. M. Donini, T. Vilardo, and R. M. Corbo, “Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of ε4 allele with AD in Italian octogenarian patients,” Neuroscience Letters, vol. 201, no. 3, pp. 231–234, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. J. C. De la Torre, “Alzheimer disease as a vascular disorder: nosological evidence,” Stroke, vol. 33, no. 4, pp. 1152–1162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Salustri, F. Tecchio, F. Zappasodi et al., “Cortical excitability and rest activity properties in patients with depression,” Journal of Psychiatry and Neuroscience, vol. 32, no. 4, pp. 259–266, 2007. View at Google Scholar · View at Scopus